Literature DB >> 19072840

Amyloid beta-protein fragments 25-35 and 31-35 potentiate long-term depression in hippocampal CA1 region of rats in vivo.

Li Cheng1, Wen-Juan Yin, Jun-Fang Zhang, Jin-Shun Qi.   

Abstract

Amyloid beta-protein (Abeta) is thought to be responsible for the deficit of learning and memory in Alzheimer's disease (AD), possibly through interfering with synaptic plasticity in the brain. It has been reported that Abeta fragments suppress the long-term potentiation (LTP) of synaptic transmission. However, it is unclear whether Abeta fragments can regulate long-term depression (LTD), an equally important form of synaptic plasticity in the brain. The present study investigates the effects of Abeta fragments on LTD induced by low frequency stimulation (LFS) in the hippocampus in vivo. Our results showed that (1) prolonged 1-10 Hz of LFS all effectively elicited LTD, which could persist for at least 2 h and be reversed by high frequency stimulation (HFS); (2) the effectiveness of LTD induction depended mainly on the number of pulses but not the frequency of LFS; (3) pretreatment with Abeta fragment 25-35 (Abeta(25-35), 12.5 and 25 nmol) did not change baseline field excitatory postsynaptic potentials but dose-dependently potentiated LTD; (4) Abeta fragment 31-35 (Abeta(31-35)), a shorter Abeta fragment than Abeta(25-35), also dose-dependently strengthened LFS-induced hippocampal LTD. Thus, the present study demonstrates the enhancement of hippocampal LTD by Abeta in in vivo condition. We propose that Abeta-induced potentiation of LTD, together with the suppression of LTP, will result in the impairment of cognitive function of the brain. (c) 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19072840     DOI: 10.1002/syn.20599

Source DB:  PubMed          Journal:  Synapse        ISSN: 0887-4476            Impact factor:   2.562


  19 in total

Review 1.  Alzheimer's disease amyloid beta-protein and synaptic function.

Authors:  Tomas Ondrejcak; Igor Klyubin; Neng-Wei Hu; Andrew E Barry; William K Cullen; Michael J Rowan
Journal:  Neuromolecular Med       Date:  2009-09-16       Impact factor: 3.843

2.  Interaction of endogenous tau protein with synaptic proteins is regulated by N-methyl-D-aspartate receptor-dependent tau phosphorylation.

Authors:  Siddhartha Mondragón-Rodríguez; Emilie Trillaud-Doppia; Anthony Dudilot; Catherine Bourgeois; Michel Lauzon; Nicole Leclerc; Jannic Boehm
Journal:  J Biol Chem       Date:  2012-07-25       Impact factor: 5.157

3.  Accumulated hippocampal formaldehyde induces age-dependent memory decline.

Authors:  Zhiqian Tong; Chanshuai Han; Wenhong Luo; Xiaohui Wang; Hui Li; Hongjun Luo; Jiangning Zhou; Jinshun Qi; Rongqiao He
Journal:  Age (Dordr)       Date:  2012-03-03

4.  [Gly14]-Humanin Protects Against Amyloid β Peptide-Induced Impairment of Spatial Learning and Memory in Rats.

Authors:  Li Yuan; Xiao-Jie Liu; Wei-Na Han; Qing-Shan Li; Zhao-Jun Wang; Mei-Na Wu; Wei Yang; Jin-Shun Qi
Journal:  Neurosci Bull       Date:  2016-06-15       Impact factor: 5.203

5.  Parallel age-associated changes in brain and plasma neuronal pentraxin receptor levels in a transgenic APP/PS1 rat model of Alzheimer's disease.

Authors:  Tina Bilousova; Karen Taylor; Ana Emirzian; Raymond Gylys; Sally A Frautschy; Gregory M Cole; Edmond Teng
Journal:  Neurobiol Dis       Date:  2014-11-13       Impact factor: 5.996

Review 6.  Fyn Kinase Activity and Its Role in Neurodegenerative Disease Pathology: a Potential Universal Target?

Authors:  Bianca Guglietti; Srisankavi Sivasankar; Sanam Mustafa; Frances Corrigan; Lyndsey E Collins-Praino
Journal:  Mol Neurobiol       Date:  2021-08-25       Impact factor: 5.590

Review 7.  Amyloid-Beta and Phosphorylated Tau Accumulations Cause Abnormalities at Synapses of Alzheimer's disease Neurons.

Authors:  Ravi Rajmohan; P Hemachandra Reddy
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

8.  How do Soluble Oligomers of Amyloid beta-protein Impair Hippocampal Synaptic Plasticity?

Authors:  Shaomin Li; Ganesh M Shankar; Dennis J Selkoe
Journal:  Front Cell Neurosci       Date:  2010-03-19       Impact factor: 5.505

9.  Oxidative stress and hippocampal synaptic protein levels in elderly cognitively intact individuals with Alzheimer's disease pathology.

Authors:  Stephen W Scheff; Mubeen A Ansari; Elliott J Mufson
Journal:  Neurobiol Aging       Date:  2016-03-08       Impact factor: 4.673

10.  Age and Alzheimer's disease gene expression profiles reversed by the glutamate modulator riluzole.

Authors:  A C Pereira; J D Gray; J F Kogan; R L Davidson; T G Rubin; M Okamoto; J H Morrison; B S McEwen
Journal:  Mol Psychiatry       Date:  2016-03-29       Impact factor: 15.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.